| Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial J Durant, P Clevenbergh, P Halfon, P Delgiudice, S Porsin, P Simonet, ... The Lancet 353 (9171), 2195-2199, 1999 | 959 | 1999 |
| Meta-analyses of FibroTest diagnostic value in chronic liver disease T Poynard, R Morra, P Halfon, L Castera, V Ratziu, F Imbert-Bismut, ... BMC gastroenterology 7, 1-11, 2007 | 452 | 2007 |
| CpG methylation controls reactivation of HIV from latency J Blazkova, K Trejbalova, F Gondois-Rey, P Halfon, P Philibert, ... PLoS pathogens 5 (8), e1000554, 2009 | 407 | 2009 |
| Hepatitis C virus resistance to protease inhibitors P Halfon, S Locarnini Journal of hepatology 55 (1), 192-206, 2011 | 401 | 2011 |
| CMV drives clonal expansion of NKG2C+ NK cells expressing self‐specific KIRs in chronic hepatitis patients V Béziat, O Dalgard, T Asselah, P Halfon, P Bedossa, A Boudifa, ... European journal of immunology 42 (2), 447-457, 2012 | 329 | 2012 |
| HCV direct‐acting antiviral agents: the best interferon‐free combinations R Schinazi, P Halfon, P Marcellin, T Asselah Liver International 34, 69-78, 2014 | 304 | 2014 |
| Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages T Poynard, P Halfon, L Castera, M Munteanu, F Imbert-Bismut, V Ratziu, ... Clinical Chemistry 53 (9), 1615-1622, 2007 | 288 | 2007 |
| Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study J Durant, P Clevenbergh, R Garraffo, P Halfon, S Icard, P Del Giudice, ... Aids 14 (10), 1333-1339, 2000 | 279 | 2000 |
| SAFE biopsy: a validated method for large‐scale staging of liver fibrosis in chronic hepatitis C G Sebastiani, P Halfon, L Castera, S Pol, DL Thomas, A Mangia, ... Hepatology 49 (6), 1821-1827, 2009 | 241 | 2009 |
| Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus P Halfon, M Bourlière, G Pénaranda, R Deydier, C Renou, ... Comparative hepatology 4, 1-7, 2005 | 224 | 2005 |
| Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients C Solas, A Lafeuillade, P Halfon, S Chadapaud, G Hittinger, B Lacarelle Antimicrobial agents and chemotherapy 47 (1), 238-243, 2003 | 219 | 2003 |
| Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection E Patin, Z Kutalik, J Guergnon, S Bibert, B Nalpas, E Jouanguy, ... Gastroenterology 143 (5), 1244-1252. e12, 2012 | 214 | 2012 |
| Independent prospective multicenter validation of biochemical markers (fibrotest–actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis … P Halfon, M Bourliere, R Deydier, D Botta-Fridlund, C Renou, A Tran, ... Official journal of the American College of Gastroenterology| ACG 101 (3 …, 2006 | 207 | 2006 |
| Mechanistic basis for reduced viral and enzymatic fitness of HIV-1 reverse transcriptase containing both K65R and M184V mutations J Deval, KL White, MD Miller, NT Parkin, J Courcambeck, P Halfon, ... Journal of Biological Chemistry 279 (1), 509-516, 2004 | 204 | 2004 |
| Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid‐based cytology in primary cervical cancer screening: the FASE study J Monsonego, MG Hudgens, L Zerat, JC Zerat, K Syrjänen, P Halfon, ... International Journal of Cancer 129 (3), 691-701, 2011 | 195 | 2011 |
| Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: results of a multicenter, large-scale study G Sebastiani, D Tempesta, G Fattovich, L Castera, P Halfon, M Bourliere, ... Journal of hepatology 53 (4), 630-638, 2010 | 192 | 2010 |
| FibroTest-ActiTest as a non-invasive marker of liver fibrosis P Halfon, M Munteanu, T Poynard Gastroenterologie clinique et biologique 32 (6), 22-39, 2008 | 186 | 2008 |
| Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study C Payan, F Roudot‐Thoraval, P Marcellin, N Bled, G Duverlie, ... Journal of viral hepatitis 12 (4), 405-413, 2005 | 185 | 2005 |
| Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies M Bourliere, G Penaranda, C Renou, D Botta‐Fridlund, A Tran, I Portal, ... Journal of viral hepatitis 13 (10), 659-670, 2006 | 181 | 2006 |
| Relapse of hepatitis C virus–associated mixed cryoglobulinemia vasculitis in patients with sustained viral response DA Landau, D Saadoun, P Halfon, M Martinot‐Peignoux, P Marcellin, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2008 | 173 | 2008 |
